Marie‐Louise Lehmann

453 total citations
13 papers, 321 citations indexed

About

Marie‐Louise Lehmann is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marie‐Louise Lehmann has authored 13 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marie‐Louise Lehmann's work include Bladder and Urothelial Cancer Treatments (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). Marie‐Louise Lehmann is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). Marie‐Louise Lehmann collaborates with scholars based in Germany, Sweden and Italy. Marie‐Louise Lehmann's co-authors include Julia Stingl, Roberto Viviani, Jürgen Brockmöller, H. Bartels, Meinolf Blaszkewicz, Klaus Golka, Silvia Selinski, Jan G. Hengstler, Walter E. Haefeli and Jürgen Burhenne and has published in prestigious journals such as Pharmacology & Therapeutics, Clinical Pharmacokinetics and British Journal of Clinical Pharmacology.

In The Last Decade

Marie‐Louise Lehmann

12 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marie‐Louise Lehmann Germany	9	133	88	61	60	38	13	321
Ken Thummel United States	6	125 0.9×	52 0.6×	51 0.8×	23 0.4×	24 0.6×	10	337
Aanchal Mehrotra United States	14	220 1.7×	123 1.4×	105 1.7×	43 0.7×	51 1.3×	19	536
Jin‐Ying Lu Taiwan	12	97 0.7×	42 0.5×	44 0.7×	31 0.5×	14 0.4×	27	466
Shunsuke Eguchi Japan	9	111 0.8×	61 0.7×	36 0.6×	33 0.6×	53 1.4×	20	314
M. Carrella Italy	9	76 0.6×	110 1.3×	93 1.5×	82 1.4×	48 1.3×	22	379
Jingmeng Sun China	12	211 1.6×	76 0.9×	52 0.9×	17 0.3×	33 0.9×	18	456
Dany Chevalier France	15	192 1.4×	213 2.4×	106 1.7×	17 0.3×	46 1.2×	23	589
Jacqueline Marti-Jaun Switzerland	10	128 1.0×	198 2.3×	92 1.5×	30 0.5×	20 0.5×	15	463
Midhun C. Korrapati United States	13	152 1.1×	144 1.6×	40 0.7×	68 1.1×	18 0.5×	14	445
Gleb Martovetsky United States	5	195 1.5×	71 0.8×	192 3.1×	57 0.9×	15 0.4×	6	515

Countries citing papers authored by Marie‐Louise Lehmann

Since Specialization

Citations

This map shows the geographic impact of Marie‐Louise Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Louise Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Louise Lehmann more than expected).

Fields of papers citing papers by Marie‐Louise Lehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie‐Louise Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Louise Lehmann. The network helps show where Marie‐Louise Lehmann may publish in the future.

Co-authorship network of co-authors of Marie‐Louise Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Marie‐Louise Lehmann. A scholar is included among the top collaborators of Marie‐Louise Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie‐Louise Lehmann. Marie‐Louise Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hoeltzenbein, Maria, Marie‐Louise Lehmann, Evelin Beck, Katarina Dathe, & Christof Schaefer. (2021). Ivabradine use in pregnant women—treatment indications and pregnancy outcome: an evaluation of the German Embryotox database. European Journal of Clinical Pharmacology. 77(7). 1029–1037. 5 indexed citations

Mikus, Gerd, et al.. (2020). Application of a microdosed cocktail of 3 oral factor Xa inhibitors to study drug–drug interactions with different perpetrator drugs. British Journal of Clinical Pharmacology. 86(8). 1632–1641. 14 indexed citations

Lehmann, Marie‐Louise, Kathrin I. Foerster, Jürgen Burhenne, et al.. (2019). Perpetrator effects of ciclosporin (P‐glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers. British Journal of Clinical Pharmacology. 85(7). 1528–1537. 24 indexed citations

Mikus, Gerd, et al.. (2019). Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug–Drug Interactions with Potential Perpetrator Drugs. Clinical Pharmacokinetics. 58(9). 1155–1163. 11 indexed citations

Lehmann, Marie‐Louise, Alexander Kreß, Michael C. Truß, et al.. (2017). Micro-brushing-based technique to gain fresh urothelial cells for gene expression analysis. Journal of Toxicology and Environmental Health. 80(7-8). 411–416.

Stingl, Julia, Marie‐Louise Lehmann, Kathrin Kastenmüller, et al.. (2016). Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial. BMC Family Practice. 17(1). 49–49. 12 indexed citations

Kleinbeck, Stefan, Michael Schäper, Stephanie Juran, et al.. (2016). Interindividual differences in chemosensory perception: Toward a better understanding of perceptual ratings during chemical exposures. Journal of Toxicology and Environmental Health. 79(22-23). 1026–1040. 9 indexed citations

Scholl, Catharina, Roberto Viviani, Alessandro Serretti, et al.. (2015). CHL1 , ITGB3 and SLC6A4 Gene Expression and Antidepressant Drug Response: Results from the Munich Antidepressant Response Signature (MARS) Study. Pharmacogenomics. 16(7). 689–701. 17 indexed citations

Stingl, Julia, H. Bartels, Roberto Viviani, Marie‐Louise Lehmann, & Jürgen Brockmöller. (2013). Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review. Pharmacology & Therapeutics. 141(1). 92–116. 139 indexed citations

10.

Viviani, Roberto, Marie‐Louise Lehmann, & Julia Stingl. (2013). Use of magnetic resonance imaging in pharmacogenomics. British Journal of Clinical Pharmacology. 77(4). 684–694. 7 indexed citations

11.

Selinski, Silvia, Meinolf Blaszkewicz, Marie‐Louise Lehmann, Jan G. Hengstler, & Klaus Golka. (2012). Genotype at the NAT2 gene, phenotype and relevance for occupational bladder cancer. Toxicology Letters. 211. S29–S30. 1 indexed citations

12.

Овсянников, Д Ю, Silvia Selinski, Marie‐Louise Lehmann, et al.. (2012). Polymorphic Enzymes, Urinary Bladder Cancer Risk, and Structural Change in the Local Industry. Journal of Toxicology and Environmental Health. 75(8-10). 557–565. 42 indexed citations

13.

Golka, Klaus, Silvia Selinski, Marie‐Louise Lehmann, et al.. (2011). Genetic variants in urinary bladder cancer: collective power of the “wimp SNPs”. Archives of Toxicology. 85(6). 539–554. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact